Healthy Extracts Inc. (OTCQB: HYEX) — Reports Preliminary Record Q3 Revenue; Growth in Subscription Channels and Gummy USA Integration
Overview
Healthy Extracts Inc. (“Healthy Extracts” or the “Company”) announced preliminary unaudited results for the third quarter of 2025, indicating a record performance with net revenue expected to total approximately US $920,000, representing a 23% increase year-over-year.
The company’s subscription-based recurring revenue channels continued to expand, led by a 98% increase in Amazon “Subscribe & Save” customers and a 58% increase in direct-to-consumer (DTC) subscribers. These recurring sales streams now represent a growing portion of overall cash flow and customer retention.
Healthy Extracts’ preliminary Q3 results precede the contribution from Gummy USA, which completed its merger with the Company at the beginning of Q4 2025. A follow-on order of 6 million gummies has already been confirmed post-merger and is expected to positively impact Q4 results.
Key Developments
1. Record Q3 Revenue Performance
- Net revenue for Q3 2025 is estimated at ~US$920,000, up 23% year-over-year and marking the Company’s fourth consecutive record quarter.
- Subscription and recurring customer growth contributed to consistent margin improvement and cash flow stability.
- The reported figures exclude revenues from Gummy USA, which will begin contributing in Q4 2025.
2. Expansion Through Gummy USA Merger
- The integration of Gummy USA™, a precision-dosed nutraceutical and pharmaceutical-grade gummy manufacturer, adds significant product and market diversity.
- Gummy USA’s patent-pending SureDose™ technology provides controlled delivery and compliance benefits for both branded and private-label clients.
- The merger supports Healthy Extracts’ strategy to scale manufacturing capacity and enter new product verticals.
3. Strong Subscription Growth and Consumer Engagement
- Amazon’s “Subscribe & Save” program recorded a 98% increase in active customers, while DTC subscription customers increased 58% versus Q3 2024.
- The company continued to rank among the top three brands in its Amazon category, reflecting successful marketing and customer retention initiatives.
- Subscription channels enhance lifetime customer value (LTV) and reduce acquisition costs.
4. New Product Categories and R&D Pipeline
- During the quarter, Healthy Extracts launched three new formulations focused on sleep support and gut health, expanding beyond its established heart and brain health lines.
- Cross-promotion across multiple online and retail channels continues to strengthen product awareness and incremental sales.
- The Company intends to introduce additional formulations in late 2025 and into 2026, supported by positive subscription metrics and recurring cash generation.
5. Management Commentary
CEO Don Swanson, founder of Gummy USA, stated that the Company’s continued growth “demonstrates how our well-tuned strategies are producing consistent operational performance.” He emphasized that subscription momentum, product innovation, and integration of new technologies underpin the Company’s outlook for another record year in 2025.
Context
Healthy Extracts continues to operate within a growing nutraceutical market segment characterized by increasing demand for science-based, clinically supported formulations and improved oral delivery systems. The integration of Gummy USA positions the Company across multiple distribution channels like DTC, Amazon, and institutional clients, with product offerings spanning heart, brain, and gut health.
The Company’s cash position and balance sheet flexibility also support the potential pursuit of additional M&A opportunities aimed at acquiring exclusive intellectual property or expanding market share in complementary health and wellness categories.
ArcStone Commentary
Healthy Extracts’ preliminary Q3 results demonstrate continuity in revenue growth and recurring income momentum. The combination of higher subscription penetration and integration of Gummy USA provides additional scale potential for the coming quarters.
While financial results remain preliminary and subject to audit, the operational data supports a trajectory of steady revenue expansion, increasing consumer retention, and enhanced manufacturing diversification through the Gummy USA platform.
You can read the full press release below:
About Healthy Extracts Inc.
Healthy Extracts Inc. (OTCQB: HYEX) develops, manufactures, and markets science-based nutraceuticals and oral delivery systems for heart, brain, and gut health.
Its subsidiaries include BergametNA™ and Ultimate Brain Nutrients™, which produce clinically validated natural health supplements featuring Citrus Bergamot SuperFruit™. The company’s Gummy USA™ subsidiary manufactures precision-dosed nutraceutical gummies through its SureDose™ delivery technology.
ArcStone Financial Pulse Team
Stay informed with the latest market trends from ArcStone Securities and Investments Corp. Subscribe to our newsletter for more detailed reports and analysis.
Disclaimer and Forward-Looking Statements
The information contained herein is provided by ArcStone Securities and Investments Corp. (“ArcStone”) for informational purposes only. It is not, and under no circumstances should it be construed as, an offer to sell or a solicitation of an offer to buy any securities or other financial instruments in any jurisdiction.
Certain statements contained herein may constitute “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws. Forward-looking statements are based on current expectations, estimates, and assumptions that involve known and unknown risks and uncertainties which may cause actual results or developments to differ materially from those expressed or implied. These statements often include words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “plan,” “project,” “should,” “target,” or similar expressions. Readers are cautioned not to place undue reliance on such statements, which speak only as of the date made. Except as required by law, ArcStone undertakes no obligation to update or revise any forward-looking information.
This content is not intended as investment advice or a recommendation to buy or sell any security and does not take into account the investment objectives, financial situation, or needs of any individual. Investors should consult their own professional advisors before making any investment decisions.
ArcStone Securities and Investments Corp. is not a registered broker-dealer and does not provide investment advice or recommendations. All registrable activities in the United States are conducted through ArcStone Securities, LLC and Kingswood US, both FINRA-registered broker-dealers. In Canada, on a transaction-by-transaction basis, all registrable activities are conducted through Sentinel Financial Group, a registered Exempt Market Dealer (EMD) in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, and the Northwest Territories.
The issuer featured in this article (the “Company”) is a current or recent client of ArcStone or one of its affiliates. ArcStone and/or its affiliates have received or expect to receive cash and/or equity compensation for the provision of corporate advisory, investor relations, digital media, or capital markets consulting services to the Company. This relationship represents a potential conflict of interest, as ArcStone may be perceived to have an incentive to present the Company in a favorable light. The principals, officers, directors, employees, and related entities of ArcStone and its affiliates may, from time to time, own, buy, or sell securities or derivatives of the Company or its affiliates.
